For a patient with Type 2 diabetes and established heart disease, choosing a GLP-1 agonist over insulin could provide meaningful protection against future cardiovascular events, above and beyond blood sugar control
Nausea, vomiting, a feeling of fullness
doi: 10.1016/j.cca.2019.11.003 155 De LeoVla MarcaAPetragliaF
GLP-1-based multi-target agonists demonstrate more comprehensive therapeutic efficacy compared to a single drug, pointing out the future direction of medication application
Many users find their sleep apnea symptoms improve enough to consider discontinuing CPAP therapy, though this decision should always involve your sleep medicine specialist
Simple adjustments like allowing your medication to reach room temperature before injection, proper site rotation, and correct needle angle can eliminate nearly all discomfort